|

Miricorilant Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Corcept Therapeutics1

Indications

  • Metabolic Dysfunction-Associated Steatohepatitis (MASH)1
  • Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)1
  • Nonalcoholic Steatohepatitis (NASH)1
  • Liver Disease1
  • Non-alcoholic Fatty Liver Disease NAFLD1

Columbia, Missouri1 trial

Evaluation of Miricorilant on Liver Fat in Patients With MASLD

University of Missouri

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.